MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.
Michael BaboudjianAlessandro UleriJean-Baptiste BeauvalAlae TouzaniRomain DiamandJean-Baptiste RocheVito LaceteraEric LechevallierThierry RoumeguèreGiuseppe SimoneDaniel BenamranAlexandre FourcadeGaelle FiardAlexandre PeltierGuillaume PloussardPublished in: Prostate cancer and prostatic diseases (2023)
Our data support extending the inclusion criteria to ISUP 2 men with >25% positive cores, provided they have a low tumor size at mpMRI (<15 mm). Prospective studies should be performed to validate these findings.
Keyphrases
- radical prostatectomy
- prostate cancer
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- magnetic resonance imaging
- peritoneal dialysis
- contrast enhanced
- electronic health record
- ultrasound guided
- machine learning
- patient reported outcomes
- deep learning
- artificial intelligence
- data analysis
- patient reported